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Introduction
Cardiovascular diseases are identifi ed as the leading cause 
of mortality at the global level [1, 2, 3, 4] and national level, as 
well [5, 6]. Ischeamic heart disease, cerebrovascular diseases 
and hypertensive disease are referred by World Health 
Organization (WHO) as major cardiovascular diseases due 
to their high proportional mortality contribution [1, 2]. In 
the Republic of Moldova major contribution cardiovascular 
diseases are a part of 96.6 %, compared to 85% estimated on 
the global level in 2011 [1,2,7]. 
Unlike the traditional analyzing of mortality pheno-
menon, statistical indicator Years of Potential Life Lost 
(YPLL), proposed by the Global Burden of Disease 1990 
study to estimate the burden of disease in a population [8], 
moves target from classical focus on the occurrence of deaths 
to focus on the losses caused by these deaths [7, 9]. Th e World 
Health Organization notes that the majority of premature 
deaths are avoidable, underlining the importance of a 25% 
reduction of premature mortality from noncommunicable 
diseases by 2025 in the world [2, 10]. In addition, the event 
of premature death is recognized as basic point of population 
health assessment [11, 12, 13], along with economic impact 
evaluation [14]. 
Aligning to the global eff orts to prevent and control non-
communicable diseases, including cardiovascular diseases, 
the Government of the Republic of Moldova has undertaken 
to reduce the avoidable burden of non-communicable dis-
eases and risk factors for the years 2012-2020, adopted in 
the legislative and normative documents at the country level 
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Abstract
Background: Cardiovascular disease is the leading cause of mortality at the global and national level. Ischeamic heart diseases, cerebrovascular diseases 
and hypertensive heart disease together identify a highest proportional mortality that defines them as major contribution cardiovascular diseases 
worldwide. Premature mortality analyzing compared to traditional moves target from classical focus on the occurrence of deaths to focus on the losses 
caused by these deaths. The purpose of the study is to assess the premature mortality evolution from major cardiovascular diseases among adults in the 
Republic of Moldova for the period of 2003-2015.
Material and methods: the research is a descriptive population study over the time of 13 years. The premature mortality phenomenon was counted in 
the years of potential life lost (YPLL). Age-adjusted rates were calculated using the direct method of standardization applying WHO World Standard 
Population Distribution (%) based on world average population between 2000-2025.
Results: Overall period from 2003 to 2015, premature mortality rate from ischeamic heart diseases (+10.7%) and hypertensive heart disease (+41%) 
have registered increasing trends versus premature mortality rate from cerebrovascular diseases with decreasing trend (-23.9%). All together determined 
the decreasing trend (-2.4%) of major cardiovascular diseases premature mortality rate. When analyzing percentage changes of premature mortality 
increasing trends by age, the study findings identified the higher percentage changes in younger groups for ischeamic heart diseases premature deaths 
than hypertensive heart disease.
Conclusions:  Despite the general decreasing trend of major cardiovascular diseases premature mortality rate, ischemic heart diseases compared to 
cerebrovascular and hypertensive heart disease identify the most pronounced trends of the deaths event rejuvenation in the Republic of Moldova for the 
period 2003-2015.
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[15,16].  Relative reducing (10%) of premature mortality 
from cardiovascular diseases is one of the targets of the Re-
public of Moldova by 2020 in terms of control and preven-
tion of noncomunicable diseases [17, 18]. 
Th e study purpose is to assess the premature mortality 
evolution from major cardiovascular diseases for the period 
of 2003-2015 in order to highlight their impact on the popu-
lation health in the Republic of Moldova.
Material and methods
Th e research design was a descriptive population study 
in terms of premature mortality evolution for the period 
from 2003 to 2015 in the Republic of Moldova. Th e primary 
source of data collection was death certifi cate (form No 
106/e) approved for application in the country since 2004. 
Th ere were considered all deaths cases registered by the 
National Center of Health Management in collaboration 
with National Bureau of Statistics of the Republic of Moldova 
overall period 2003-2015 [5, 6]. 
Th e premature mortality phenomenon was counted in 
the years of potential life lost (YPLL) according the following 
formula (1):
YPLL =   (1)  
Where: 
n – Number of fi ve years age groups;
di – Number of deaths in each fi ve years age group;
70 – End point age;
DOI: 10.5281/zenodo.1051156
UDC: 616.1-036.8:614.2(478)
RESEARCH STUDIES The Moldovan Medical Journal, October 2017, Vol. 60, No 3
ai – Midpoint interval of each fi ve years age group.
Th e rate of premature mortality (YPLL Rate) was 
calculated according the formula (2):
YPLL Rate = 
Number of IPLL
Number of population under 70 years age
´ 100.000  (2) 
Age adjusted premature mortality rate was calculated 
using the steps of direct method of standardization, which 
allows comparisons between the sexes and geographical areas 
by considering a conventional population assuming that the 
age structure is the same in both sexes.  Th ere was applied 
as a standard for years of potential life lost adjustment rates 
of the WHO World Standard Population Distribution (%) 
based on world average population between 2000-2025 [19]. 
Results
Major cardiovascular diseases (I20-I25; I60-I69; I11)
In 2015, major cardiovascular diseases registered 
22,018 deaths that resulted in 61,448 potential years of life 
lost (PYLL). Major cardiovascular diseases caused about 
66.9% of all deaths from noncommunicable diseases in 
the Republic of Moldova. Major cardiovascular diseases 
premature deaths were identifi ed in a proportion of 38.9% 
from total noncommunicable diseases and 21.8% from all 
causes of deaths in 2015.
Diseases of the circulatory system are the leading cause in 
the all causes of proportional mortality rate (58%), structured 
in 95.6% (in 2015) by three clinical forms, as following: 
ischeamic heart diseases (62%), cerebrovascular diseases 
(25,3 %), and hypertensive heart disease (8.3%), referred as 
major cardiovascular diseases. Major cardiovascular diseases 
identifi ed deaths under the age of 65 year in 19.3% (95% CI 
18.8% - 19.8%), indicating that about one in fi ve deaths is 
produced in premature age. Proportional mortality rate 
from major cardiovascular disease by gender determined 
44.6% (95% CI 44.0% - 45.3%) for males and 55.4% (95% 
IC 54.7% 56.0%) for females. Along with the fact that the 
distribution of deaths under 65 years of age from major 
cardiovascular diseases registered a higher proportion for 
males 67.2% (95% CI 65.8% - 68.6%) compared to women 
32.8% (95% IC 31.4% - 34.2%). Th e distribution of deaths 
from major cardiovascular diseases for men aged less than 
65 years was 29.0% (95% IC 28.1% - 29.9%): approximately 
every third male’s death from major cardiovascular diseases 
was in premature age. Th e distribution of deaths from major 
cardiovascular diseases for women aged less than 65 years 
was 11.4% (95% IC 10.9% - 12.0%): about one in nine deaths 
by major cardiovascular diseases in women were premature. 
Age-standardized rates of premature mortality from 
major cardiovascular diseases were permanent higher 
for age group 40-64 years for the overall period 2003-
2015, ranging from 1034.8 (in 2013) to 1406.2 (in 2005) 
per 100,000 population. Standardized rates of premature 
mortality from major cardiovascular diseases in total were 
decreasing from 1,648.1 to 1,321.7 per 100,000 population 
for the period from 2003 to 2015. Standardized rates of 
premature death by age from major cardiovascular diseases 
have been decreased for ages 40-64 (from 1331.1 to 1048.5 
per 100,000 population) and over 65 years (from 170.3 to 
120,8 per 100,000 population), along with it an increase 
of standardized rates was registered for group 18-39 years 
(from 141.7 to 149.6 per 100,000 population).
Adjusted rates were higher for men (ranging from 1932.8 
in 2013 to 2475.7 in 2005 per 100,000 population) compared 
to women (ranging from 733.7 in 2015 to 1181.6 in 2003 per 
100,000 population), including all age groups in question: 
18-39; 40-64; 65+ years, and productive years of age. Over the 
period 2003-2015 standardized rates of premature mortality 
from major cardiovascular diseases have decreased for both 
sexes: in males from 2,202.6 to 1,995.1 and in females from 
1,181.6 to 733.7 per 100,000 population. Age-adjusted rate 
of premature mortality from major cardiovascular diseases 
in males compared to women is 2.7 times higher (in 2015). 
Standardized rates of premature mortality from major 
cardiovascular diseases by gender and age have shown a 
decrease for the majority of age groups analyzed in males 
and females, except in the 18-39 age groups in males, which 
showed a relative increase from 198.4 to 220.5 per 100,000 
populations.
From 2003 to 2015 percentage change in major cardio-
vascular diseases premature mortality rate registered de-
creasing trend in total (-2.4%), along with rising trend in 
males (+ 9.8%) and decreasing trend in women (-22%). In 
addition, there were found the rising percentage changes in 
premature mortality rate from major cardiovascular diseases 
only in age group 18-39 years (+20.1%) versus decreasing 
percentage changes trends in age group 40-64 years (-11%), 
age group over 65 years (-29.1%) and  productive years age 
group (-7.6%) (fi g. 1).
With the general description of the major cardiovascular 
diseases, it is very important the descriptive analysis by 
clinical forms, which are the component parts of major 
cardiovascular diseases phenomenon, as follows:
Ischeamic Heart Diseases (I20-I25)
Ischeamic heart diseases are the leading cause of 
mortality of men and women in the Republic of Moldova 
with an average of 15,407 annual deaths overall period 2003-
2015, which in 19% (95% CI 18.4% - 19.7%) cases are deaths 
under 65 years of age. Along with, every fi ft h death from 
ischeamic heart diseases was in premature age, ischeamic 
heart diseases produced more than a half (62%) of deaths 
from the diseases of circulatory system and more than 1/3 of 
total annual deaths.  In 2015, ischeamic heart diseases have 
counted a number of 14,275 cases which produced 39,832 
potential years of life lost (PYLL). Proportion of premature 
deaths from ischeamic heart diseases was determined in 
64.8% from major cardiovascular diseases and in 14.1% 
from all causes of deaths in 2015.
For the period 2003-2015 age-standardized rates of 
premature mortality from ischeamic heart diseases were 
permanently higher for age group 40-64 years, ranging from 
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670.7 (in 2011) to 806.9 (in 2005) per 100,000 population. 
Adjusted rates of premature deaths from ischeamic heart 
diseases in men were higher (ranging from 1309.1 in 2011 
to 1579.2 in 2005 than in women ranging from 426.6 in 
2011 to 616.1 in 2012 per 100,000 population), inclusively 
all analyzed age groups, as follows: 18-39; 40-64; 65+ years, 
and productive years of age.
Th e percentage change in premature mortality caused by 
ischeamic heart diseases for the period 2003-2015 showed 
growth trends for all age groups except the age group over 65 
years. Rising trends of premature mortality were determined 
as +38.1% for age group 18-39, +2.9%  for age group 40-64 
years, and +4.8% for group of productive years age (fi g.1).
Fig. 1.  Percentage change in major cardiovascular diseases 
premature mortality rates among adults, 
the Republic of Moldova, 2003-2015.
Th e increasing trends of percentage change in  overall 
premature mortality from ischeamic heart diseases (+10.7%) 
wa s largely determined by the rising trends of premature 
mortality in men for all age groups. In addition, premature 
mortality rising trends for men were higher in younger age 
groups lying from + 38.2% for age group 18-39 years to + 
13.0% for age group 40-64 years.
Cerebrovascular Diseases (I60-I69)
In 2015, cerebrovascular diseases recorded 5,835 
deaths producing 19,302 potential years of life lost (PYLL). 
Cerebrovascular diseases were responsible for 31.4% of all 
PYLL from major cardiovascular diseases and a proportion 
of 7% from all causes of deaths in 2015.
Proportional mortality from cerebrovascular diseases 
by age was 22.8% (95% IC 21.8%-23.9%) in case of age 
groups under 65 years. In 2015, every fi ft h death from 
cerebrovascular diseases was in premature ages. 
Age-standardized rates of premature mortality from 
cerebrovascular diseases were higher for age group 40-64 
years overall period from 2003 to 2015, ranging from 320.9 
(in 2013) to 563.3 (in 2005) per 100,000 population. Adjusted 
rates of premature mortality from cerebrovascular disease by 
gender were higher in case of men (ranging from 595.5 in 
2012 to 837.6 in 2005) than in women (ranging from 258.3 
in 2015 to 566.8 in 2005 per 100,000 population), inclusively 
all analyzed age groups, as follows: 18-39; 40-64; 65+; and 
productive years of age.
Th e percentage change of rates in premature mortality 
from cerebrovascular diseases for the period 2003-2015 
registered decreasing trends for both men and women, with 
the exception of men aged 18-39 years with rising trend 
of +22.5%. Th e percentage change in premature mortality 
caused by cerebrovascular diseases for the period 2003-2015 
showed decreasing trends for all age groups in question 
(fi g.1). In addition, it was found that decreasing trend of 
percentage changes in premature mortality rates from 
cerebrovascular diseases for women was 3.6 times higher 
compared to men.
Hypertensive Heart Disease (I11)
In 2015, hypertensive heart disease recorded 1,908 deaths 
producing 2,312.5 potential years of life lost (PYLL), which 
determined 3.8% of total PYLL from major cardiovascular 
diseases. 
Premature deaths from ischeamic heart disease were 
associated with hypertension in 21.2% of total premature 
deaths cases which were responsible for 9.4% of total 
potential years of life lost produced by this disease. Premature 
deaths from cerebrovascular disease were associated with 
hypertension in 40.7% of total premature deaths cases which 
were responsible for 30% of total potential years of life lost 
produced by this disease. Age-standardized premature 
mortality rates from cerebrovascular disease associated with 
hypertension identifi ed higher frequencies compared to 
ischeamic heart disease associated with hypertension (1.9 
times) and hypertensive heart disease (3.2 times).
Age-adjusted rates of premature mortality from 
hypertensive heart disease by gender registered higher level 
for men compared to women, respectively ranging from 38.0 
(in 2012) to 61.8 (in 2014), and from 27.1 (in 2009) to 41.7 
(in 2007) per 100,000 population. In addition, for both sexes 
the age group 40-64 years identifi ed higher frequencies than 
age groups: 18-39; over 65, and productive years of age.
Th e percentage change of rates in premature mortality 
from hypertensive heart disease for the period from 2003 
to 2015 recorded an increasing trend (+41%), along with a 
rising percentage  for age group 40-64 years  (+27.3%) and 
over 65 years (99.1%) (fi g.1). Evolution of hypertensive heart 
disease by gender identifi ed higher percentage change in 
women (+67.5%) than men (23.9%) overall period 2003-
2015.
Discussion
Along with general decreasing trend of major 
cardiovascular diseases premature mortality rate (-2.4%) 
for the period 2003-2015, the study found when referring 
to every clinical form in question: ischeamic heart diseases, 
cerebrovascular diseases and hypertensive heart disease the 
trends of premature mortality rates were diff erent.  Overall 
period from 2003 to 2015, premature mortality rates from 
ischeamic heart diseases (+10.7%) and hypertensive heart 
disease (+41%)  have registered increasing trends versus 
premature mortality rate from cerebrovascular diseases with 
decreasing trend (-23.9%).
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When analyzing percentage changes of premature 
mortality increasing trends by age, the study fi ndings 
determined  the higher percentage changes in younger 
groups for ischeamic heart diseases premature deaths than 
hypertensive heart disease, respectively as following: age 
group 18-39 years ( +38.1%  ), 40-64 years ( +2.9% ) , over 65 
years (- 32.1%) and age group 18-39 years (a small number 
of cases was  registered), 40-64 years (+27.3%), over 65 
years (+99.1% ). Th ese diff erences over the time in mortality 
changes are of great epidemiologic interest because of 
resulting possibilities for comparative investigation [20, 21, 
22]. Mostly similar trends were found by Global Burden 
Disease study (GBD-2010), which estimated for the period 
1990-2010 along with a slightly decreasing from major 
cardiovascular diseases premature mortality rates, there was 
also an increase of 17-28% for the potential years life lost 
from ischeamic heart diseases and cerebrovascular diseases 
[8, 9].
Conclusions
1. Despite the general decreasing trend of major cardio-
vascular diseases premature mortality rate, ischeamic heart 
diseases compared to cerebrovascular and hypertensive heart 
diseases identify the most pronounced trends of the deaths 
event rejuvenation in the Republic of Moldova for the period 
2003-2015.  
2. The systematic evaluation of premature mortality 
changes contributes to improve the quality assessment of 
the population health and evidence-based decision-making 
regarding the cardiovascular diseases prevention and control 
in the Republic of Moldova.
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